DE69033699D1 - Gegenüber eigenen inhibitoren resistente t-pa mutanten - Google Patents
Gegenüber eigenen inhibitoren resistente t-pa mutantenInfo
- Publication number
- DE69033699D1 DE69033699D1 DE69033699T DE69033699T DE69033699D1 DE 69033699 D1 DE69033699 D1 DE 69033699D1 DE 69033699 T DE69033699 T DE 69033699T DE 69033699 T DE69033699 T DE 69033699T DE 69033699 D1 DE69033699 D1 DE 69033699D1
- Authority
- DE
- Germany
- Prior art keywords
- mutants
- serine protease
- inhibitors
- mutants resistant
- encode
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6456—Plasminogen activators
- C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- C07K14/8132—Plasminogen activator inhibitors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21069—Protein C activated (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31921289A | 1989-03-06 | 1989-03-06 | |
US07/434,748 US5550042A (en) | 1989-03-06 | 1989-11-13 | Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the same |
PCT/US1990/000947 WO1990010649A1 (en) | 1989-03-06 | 1990-03-01 | Serpin resistant chymotrypsin superfamily proteases, particularly pai-1 resistant +-pa, complementary inhibitor mutants; compositions; genes; expression |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69033699D1 true DE69033699D1 (de) | 2001-03-15 |
DE69033699T2 DE69033699T2 (de) | 2001-05-23 |
Family
ID=23241316
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69033699T Expired - Lifetime DE69033699T2 (de) | 1989-03-06 | 1990-03-01 | Gegenüber eigenen inhibitoren resistente t-pa mutanten |
DE69034013T Expired - Lifetime DE69034013T2 (de) | 1989-03-06 | 1990-03-01 | Serpin-resistenter T-PA; Mutanten; Gene |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69034013T Expired - Lifetime DE69034013T2 (de) | 1989-03-06 | 1990-03-01 | Serpin-resistenter T-PA; Mutanten; Gene |
Country Status (10)
Country | Link |
---|---|
US (1) | US5728564A (de) |
EP (2) | EP0462207B1 (de) |
JP (3) | JP2991769B2 (de) |
AT (2) | ATE226636T1 (de) |
AU (1) | AU637791B2 (de) |
CA (1) | CA2047702C (de) |
DE (2) | DE69033699T2 (de) |
DK (2) | DK0462207T3 (de) |
ES (2) | ES2185529T3 (de) |
WO (1) | WO1990010649A1 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5262170A (en) * | 1988-09-02 | 1993-11-16 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells |
US5714145A (en) * | 1988-09-02 | 1998-02-03 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties |
US5866413A (en) * | 1989-03-06 | 1999-02-02 | Board Of Regents Of The University Of Texas System | Pai-1 mutants |
CA2071630C (en) * | 1989-12-29 | 2000-02-22 | Donald C. Foster | Hybrid protein c |
US5358932A (en) * | 1989-12-29 | 1994-10-25 | Zymogenetics, Inc. | Hybrid protein C |
GB9011861D0 (en) * | 1990-05-26 | 1990-07-18 | Beecham Group Plc | Novel compounds |
ES2067326T3 (es) * | 1990-12-18 | 1995-03-16 | Genentech Inc | Variante especifica de activador de plasminogeno tisular. |
DK0643772T3 (da) * | 1992-06-03 | 1998-02-02 | Genentech Inc | Glycosyleringsvarianter af vævsplasminogenaktivator med forbedrede terapeutiske egenskaber |
GB9216558D0 (en) * | 1992-08-04 | 1992-09-16 | British Bio Technology | Modified proteases |
US5567602A (en) * | 1992-08-12 | 1996-10-22 | Arris Pharmaceutical Corporation | Recombinant production of chymase |
ES2080657B1 (es) * | 1993-09-27 | 1996-11-01 | Britisch Bio Technology Limite | Proteasas modificadas. |
EP0958833A1 (de) * | 1998-05-20 | 1999-11-24 | Erasmus Universiteit Rotterdam | Verfahren und Mittel zur Vorbeugung oder Behandlung der Entzündung |
AUPP508798A0 (en) | 1998-08-05 | 1998-08-27 | Biotech Australia Pty Limited | Method of treating psoriasis |
WO2001066771A2 (en) * | 2000-03-03 | 2001-09-13 | Zymogenetics, Inc. | Human serine protease |
US6673623B1 (en) | 2000-09-12 | 2004-01-06 | Novocure, Inc. | Methods and compositions that control lipid production |
AU2002305052A1 (en) | 2001-03-13 | 2002-09-24 | Corvas International, Inc. | Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon |
WO2002077263A2 (en) | 2001-03-22 | 2002-10-03 | Dendreon San Diego Llc | Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon |
NZ527971A (en) | 2001-03-27 | 2006-03-31 | Dendreon Corp | Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon |
KR20040080940A (ko) | 2001-05-14 | 2004-09-20 | 덴드레온 코포레이션 | 트랜스막 세린 프로테아제 10을 암호화하는 핵산 분자,암호화된 폴리펩티드 및 이에 근거한 방법 |
US20050137094A1 (en) * | 2001-06-11 | 2005-06-23 | Halliburton Energy Sevices, Inc. | Subterranean formation treatment fluids and methods of using such fluids |
US6488091B1 (en) * | 2001-06-11 | 2002-12-03 | Halliburton Energy Services, Inc. | Subterranean formation treating fluid concentrates, treating fluids and methods |
US7001872B2 (en) * | 2001-06-11 | 2006-02-21 | Halliburton Energy Services, Inc. | Subterranean formation treating fluid and methods of fracturing subterranean formations |
AU2002315525A1 (en) * | 2001-07-03 | 2003-01-21 | Dendreon San Diego Llc | Nucleic acid molecules encoding a transmembrane serine protease 20, the encoded polypeptides and methods based thereon |
EP1527189A4 (de) * | 2001-07-18 | 2006-03-15 | American Nat Red Cross | Mutanten von proteinaseinhibitoren und deren anwendungen |
AU2002357004A1 (en) * | 2001-11-20 | 2003-06-10 | Dendreon San Diego Llc | Nucleic acid molecules encoding serine protease 17, the encoded polypeptides and methods based thereon |
US20040001801A1 (en) * | 2002-05-23 | 2004-01-01 | Corvas International, Inc. | Conjugates activated by cell surface proteases and therapeutic uses thereof |
US8975370B2 (en) | 2003-04-04 | 2015-03-10 | Universite De Lausanne | Inhibitor proteins of a protease and use thereof |
EP2046951B1 (de) | 2006-07-05 | 2011-10-26 | Catalyst Biosciences, Inc. | Protease-screening-verfahren und dadurch identifizierte proteasen |
EP3902913A1 (de) * | 2018-12-28 | 2021-11-03 | Catalyst Biosciences, Inc. | Modifizierte urokinaseartige plasminogenaktivatorpolypeptide und verfahren zur verwendung |
US11613744B2 (en) | 2018-12-28 | 2023-03-28 | Vertex Pharmaceuticals Incorporated | Modified urokinase-type plasminogen activator polypeptides and methods of use |
CN112375131B (zh) * | 2020-11-16 | 2021-10-01 | 西南大学 | Seroin蛋白的截短体及其应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5112755A (en) * | 1982-04-15 | 1992-05-12 | Genentech, Inc. | Preparation of functional human urokinase proteins |
AR241654A1 (es) * | 1982-05-05 | 1992-10-30 | Genentech Inc | Procedimiento para producir activador de plasminogeno de tejido humano. |
AU560584B2 (en) * | 1983-07-28 | 1987-04-09 | Bayer Aktiengesellschaft | Homologues of aprotinin |
US5073494A (en) * | 1985-04-22 | 1991-12-17 | Genentech, Inc. | Human tissue plasminogen activator substituted at position 275 or at positions 275 and 277 |
JPH084501B2 (ja) * | 1987-03-20 | 1996-01-24 | エーザイ株式会社 | 糖鎖に関する変異tPA |
MY103358A (en) * | 1987-04-15 | 1993-06-30 | Novartis Ag | Process for the production of protiens. |
US5200340A (en) * | 1987-05-22 | 1993-04-06 | Zymogenetics, Inc. | Thrombin-activated tissue plasminogen activators |
EP0292009A1 (de) * | 1987-05-22 | 1988-11-23 | Zymogenetics, Inc. | Fibrinolytische Proteine |
GB2208511A (en) * | 1987-08-07 | 1989-04-05 | Bayer Ag | Variants of bovine pancreatic trypsin inhibitor produced by recombinant dna technology |
US5188829A (en) * | 1987-08-19 | 1993-02-23 | Sagami Chemical Research Center | Rapidly acting prourokinase |
WO1989007145A1 (en) * | 1988-02-05 | 1989-08-10 | Integrated Genetics, Inc. | Modified gene sequences encoding modified tpa and products therefrom |
EP0398962A1 (de) * | 1988-02-05 | 1990-11-28 | Genzyme Corporation | Geänderte gewebsplasminogenaktivatoren und verfahren zu ihrer herstellung |
US5262170A (en) * | 1988-09-02 | 1993-11-16 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells |
US5108901A (en) * | 1988-09-02 | 1992-04-28 | Genentech, Inc. | Tissue plasminogen activator having zymogenic or fibrin specific properties |
-
1990
- 1990-03-01 AT AT00109138T patent/ATE226636T1/de not_active IP Right Cessation
- 1990-03-01 ES ES00109138T patent/ES2185529T3/es not_active Expired - Lifetime
- 1990-03-01 AU AU52780/90A patent/AU637791B2/en not_active Expired
- 1990-03-01 CA CA002047702A patent/CA2047702C/en not_active Expired - Lifetime
- 1990-03-01 WO PCT/US1990/000947 patent/WO1990010649A1/en active IP Right Grant
- 1990-03-01 DE DE69033699T patent/DE69033699T2/de not_active Expired - Lifetime
- 1990-03-01 AT AT90905081T patent/ATE199090T1/de not_active IP Right Cessation
- 1990-03-01 EP EP90905081A patent/EP0462207B1/de not_active Expired - Lifetime
- 1990-03-01 EP EP00109138A patent/EP1029921B1/de not_active Expired - Lifetime
- 1990-03-01 JP JP2505024A patent/JP2991769B2/ja not_active Expired - Lifetime
- 1990-03-01 DK DK90905081T patent/DK0462207T3/da active
- 1990-03-01 DE DE69034013T patent/DE69034013T2/de not_active Expired - Lifetime
- 1990-03-01 DK DK00109138T patent/DK1029921T3/da active
- 1990-03-01 ES ES90905081T patent/ES2154629T3/es not_active Expired - Lifetime
-
1996
- 1996-05-21 US US08/651,055 patent/US5728564A/en not_active Expired - Lifetime
-
1999
- 1999-07-23 JP JP11209788A patent/JP3076034B2/ja not_active Expired - Lifetime
- 1999-07-23 JP JP11209809A patent/JP3076035B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DE69034013T2 (de) | 2003-07-31 |
ATE226636T1 (de) | 2002-11-15 |
AU637791B2 (en) | 1993-06-10 |
EP0462207B1 (de) | 2001-02-07 |
EP1029921A1 (de) | 2000-08-23 |
DE69033699T2 (de) | 2001-05-23 |
EP0462207A4 (en) | 1992-06-24 |
JP2000078990A (ja) | 2000-03-21 |
CA2047702A1 (en) | 1990-09-07 |
ES2154629T3 (es) | 2001-04-16 |
JP3076035B2 (ja) | 2000-08-14 |
JP3076034B2 (ja) | 2000-08-14 |
JP2991769B2 (ja) | 1999-12-20 |
DE69034013D1 (de) | 2002-11-28 |
AU5278090A (en) | 1990-10-09 |
JPH04504952A (ja) | 1992-09-03 |
EP0462207A1 (de) | 1991-12-27 |
CA2047702C (en) | 2000-10-24 |
WO1990010649A1 (en) | 1990-09-20 |
DK0462207T3 (da) | 2001-06-18 |
EP1029921B1 (de) | 2002-10-23 |
DK1029921T3 (da) | 2003-02-24 |
JP2000037195A (ja) | 2000-02-08 |
ATE199090T1 (de) | 2001-02-15 |
US5728564A (en) | 1998-03-17 |
ES2185529T3 (es) | 2003-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69033699T2 (de) | Gegenüber eigenen inhibitoren resistente t-pa mutanten | |
ATE193304T1 (de) | Inhibitoren der menschlichen neutrophilenelastase | |
MX9804623A (es) | Precursores inactivos de farmacos inhibidores de trombina. | |
ES2066033T3 (es) | Inhibidores de las proteinasas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
EP0739338A4 (de) | Neue sterin-protease inhibitoren: isothiazolidin-3-on-1,1-dioxid und 3-oxo-1,2,5-thiadiazolidin 1,1-dioxid | |
MY116539A (en) | New amino acid derivatives | |
MY113489A (en) | Reversible protease inhibitors | |
ES2101516T3 (es) | Derivados peptidos de acido boronico que tienen actividad inhibidora de proteasas. | |
NO934218D0 (no) | Inhibitorer av cathepsin G og elastase for forhindring avbindevevsnedbrytning | |
DE69326077D1 (de) | Sulfonylalkanoylaminohydroxyethylaminosulfaminsäuren verwendbar als inhibitoren retroviraler proteasen | |
PT871454E (pt) | Inibidores fosforosos que contem protease de cisteina e de serina | |
ATE250574T1 (de) | Neue verbindungen | |
IL122305A0 (en) | Tace polypeptide its production and its use | |
ATE176668T1 (de) | Neue 9-n-bicyclische nucleosidverbindungen nützlich als selektive inhibitoren von proinflammatorische cytokinen | |
AU4720093A (en) | Inhibitor resistant serine proteases | |
DE69332904D1 (de) | Hemmung von hiv-infektion | |
DE69227844D1 (de) | Waschmittelzusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SY |
|
8364 | No opposition during term of opposition |